⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BBIO News
BridgeBio Pharma, Inc. Common Stock
Muscular Dystrophy Association Announces $100,000 Investment to Advance LGMD Care at Leading MDA Care Centers with BridgeBio
globenewswire.com
BBIO
Wall Street's Cardiac Bet: Where Diagnostics Meet the Money
prnewswire.com
BBIO
BMY
ARWR
AMGN
BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1
globenewswire.com
BBIO
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BBIO
Form 8-K
sec.gov
BBIO
Form 8-K
sec.gov
BBIO
BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates
globenewswire.com
BBIO
BridgeBio to Participate in May and June Investor Conferences
globenewswire.com
BBIO
BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil
globenewswire.com
BBIO
Condor Software Launches Advanced Analytics and Dynamic Scenario Suite
prnewswire.com
ACAD
BBIO
MDGL